Total Revenue
Stryker Total Revenue decreased by 16.1% to $6.02B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $5.87B to $6.02B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 10.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market demand or successful price increases, while a decrease suggests market saturation or competitive pressure.
Detailed definition
The total amount of income generated by the sale of goods or services related to the company's primary operations. For a...
Peer comparison
Peer technology firms typically report this as Net Sales or Total Revenue, reflecting the scale of their market reach.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.29B | $4.16B | $4.70B | $4.28B | $4.49B | $4.48B | $5.20B | $4.78B | $5.00B | $4.91B | $5.82B | $5.24B | $5.42B | $5.49B | $6.44B | $5.87B | $6.02B | $6.06B | $7.17B | $6.02B |
| QoQ Change | — | -3.1% | +13.0% | -9.1% | +5.1% | -0.3% | +16.1% | -8.2% | +4.6% | -1.7% | +18.5% | -9.8% | +3.4% | +1.3% | +17.1% | -8.9% | +2.7% | +0.6% | +18.4% | -16.1% |
| YoY Change | — | — | — | — | +4.6% | +7.7% | +10.7% | +11.8% | +11.2% | +9.6% | +11.8% | +9.7% | +8.5% | +11.9% | +10.7% | +11.9% | +11.1% | +10.2% | +11.4% | +2.6% |
Product Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Trauma and Extremities | $1.66B | $1.70B | $1.99B | $1.89B | $1.91B | $1.92B | $2.17B | $1.04B |
| Instruments | $1.40B | $1.36B | $1.58B | $1.46B | $1.54B | $1.52B | $1.85B | $920.00M |
| Medical | $1.82B | $1.88B | $2.28B | $1.89B | $1.98B | $1.97B | $2.57B | $902.00M |
| Endoscopy | $1.54B | $1.67B | $2.01B | $1.73B | $1.80B | $1.79B | $2.29B | $868.00M |
| Knees | $1.20B | $1.14B | $1.37B | $1.28B | $1.28B | $1.26B | $1.50B | $670.00M |
| Ortho Tech | — | — | — | — | — | — | — | $646.00M |
| Vascular | $654.00M | $658.00M | $682.00M | $812.00M | $996.00M | $1.05B | $1.08B | $517.00M |
| Hips | $856.00M | $840.00M | $926.00M | $886.00M | $932.00M | $914.00M | $998.00M | $460.00M |
| Neuro Cranial | $832.00M | $882.00M | $1.80B | $1.13B | $1.23B | $1.27B | $1.34B | — |
| Other | $272.00M | $254.00M | $632.00M | $324.00M | $366.00M | $406.00M | $534.00M | — |
| Spine | $614.00M | $608.00M | — | $332.00M | $10.00M | $12.00M | $16.00M | — |
| Total | $5.42B | $5.49B | $6.44B | $5.87B | $6.02B | $6.06B | $7.17B | $6.02B |
Neuro Cranial, Other, Other MedSurg and Neurotechnology were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| MedSurg and Neurotechnology: | $3.12B | $3.22B | $4.18B | $3.51B | $3.77B | $3.80B | $4.56B | $3.21B |
| Orthopaedics: | $2.31B | $2.27B | $2.26B | $2.36B | $2.25B | $2.25B | $2.61B | $2.81B |
| Total | $5.42B | $5.49B | $6.44B | $5.87B | $6.02B | $6.06B | $7.17B | $6.02B |
Geographic Breakdown — Europe, Middle East, Africa
| Segment | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Europe, Middle East, Africa | $2.30B | $2.35B | $2.62B | $2.90B | $3.18B |
| Asia Pacific | $1.97B | $1.89B | $1.95B | $2.02B | $2.16B |
| Other foreign countries | $515.00M | $578.00M | $677.00M | $735.00M | $765.00M |
| Total | $17.11B | $18.45B | $20.50B | $22.60B | $25.12B |
All segment values are derived from annual filings.
Geographic Breakdown — International
| Segment | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| International | $1.23B | $1.33B | $1.38B | $1.39B | $1.43B | $1.47B | $1.49B | $1.54B |
| Total | $4.91B | $5.24B | $5.42B | $5.49B | $5.87B | $6.02B | $6.06B | $6.02B |
Total Revenue at Other Companies
Frequently Asked Questions
- What is Stryker's total revenue?
- Stryker (SYK) reported total revenue of $6.02B in Q1 2026.
- How has Stryker's total revenue changed year-over-year?
- Stryker's total revenue increased by 2.6% year-over-year, from $5.87B to $6.02B.
- What is the long-term trend for Stryker's total revenue?
- Over 4 years (2021 to 2025), Stryker's total revenue has grown at a 10.1% compound annual growth rate (CAGR), from $17.11B to $25.12B.
- What does total revenue mean?
- The total amount of money a company brings in from selling its products and services.